13D/13G Filings - PROGENICS PHARMACEUTICALS INC (PGNX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-08
12:00 pm
Sale
2021-12-31 13G PROGENICS PHARMACEUTICALS INC
PGNX
FARALLON CAPITAL MANAGEMENT LLC 0
0.000%
-8,500,000decrease
(Position Closed)
Filing
History
2021-02-12
6:42 pm
Purchase
2020-12-31 13G PROGENICS PHARMACEUTICALS INC
PGNX
FARALLON CAPITAL MANAGEMENT LLC 8,500,000
9.800%
250,000increase
(+3.03%)
Filing
History
2020-06-23
10:26 am
Sale
2020-06-19 13D PROGENICS PHARMACEUTICALS INC
PGNX
Lantheus Holdings Inc.
LNTH
1,000
100.000%
-8,010,733decrease
(-99.99%)
Filing
History
2020-06-04
4:06 pm
Sale
2020-06-01 13G PROGENICS PHARMACEUTICALS INC
PGNX
EAGLE ASSET MANAGEMENT INC 31
5.000%
-4,506,253decrease
(-100.00%)
Filing
History